Back to STRS OHIO STRS OHIO

CPRXCPRX
31 quarters

Position history for STRS OHIOSTRS OHIO's holdings in CATALYST PHARMACEUTICALS INC

STRS OHIO holds 42,000 shares of CPRX (CATALYST PHARMACEUTICALS INC), worth $1.3M as of 2026-Q2. CPRX represents 0.0% of STRS OHIO's portfolio.

Current Value

$1.3M

Current Shares

42,000

Total Value Change

+$955,060

Total Shares Change

-148,600

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Unchanged
42,000
0.0%
$1.3M0.0%$31.43
0
2026-Q1
Unchanged
42,000
0.0%
$1M0.0%$23.92
0
2025-Q4
Decreased
42,000
-11.2%
$980,2800.0%$23.29
0
2025-Q3
Increased
47,300
+10.8%
$931,8100.0%$19.55
28
2025-Q2
Increased
42,700
+4.2%
$926,5900.0%$21.78
26
2025-Q1
Decreased
41,000
-7.2%
$994,2500.0%$24.69
0
2024-Q4
Decreased
44,200
-1.6%
$922,4540.0%$21.07
0
2024-Q3
Decreased
44,900
-12.3%
$892,6120.0%$19.56
0
2024-Q2
Increased
51,200
+6.0%
$793,0880.0%$15.49
26
2024-Q1
Decreased
48,300
-13.9%
$769,0000.0%$15.94
0
2023-Q4
Decreased
56,100
-5.2%
$943,0000.0%$16.81
0
2023-Q3
Unchanged
59,200
0.0%
$692,0000.0%$11.69
0
2023-Q2
Decreased
59,200
-62.3%
$795,0000.0%$13.53
0
2023-Q1
Increased
156,900
+222.2%
$2.6M0.0%$16.46
42
2022-Q4
Decreased
48,700
-22.0%
$905,0000.0%$18.60
0
2022-Q3
Decreased
62,400
-39.1%
$800,0000.0%$12.70
0
2022-Q2
Decreased
102,500
-2.1%
$718,0000.0%$6.95
0
2022-Q1
Decreased
104,700
-17.4%
$867,0000.0%$8.28
0
2021-Q4
Decreased
126,800
-20.8%
$858,0000.0%$6.89
0
2021-Q3
Increased
160,000
+11.5%
$848,0000.0%$5.02
28
2021-Q2
Decreased
143,500
-26.3%
$825,0000.0%$5.78
0
2021-Q1
Increased
194,800
+8.3%
$898,0000.0%$4.34
27
2020-Q4
Increased
179,800
+7.2%
$600,0000.0%$3.42
26
2020-Q3
Increased
167,700
+37.4%
$498,0000.0%$3.21
32
2020-Q2
Decreased
122,100
-18.1%
$564,0000.0%$4.56
0
2020-Q1
Unchanged
149,100
0.0%
$574,0000.0%$3.88
0
2019-Q4
Decreased
149,100
-37.8%
$559,0000.0%$3.67
0
2019-Q3
Increased
239,800
+42.3%
$1.3M0.0%$5.27
34
2019-Q2
Decreased
168,500
-11.6%
$647,0000.0%$3.84
0
2019-Q1
Unchanged
190,600
0.0%
$972,0000.0%$5.10
0
2018-Q4
New
190,600
-
$365,0000.0%$1.98
33

Other major holders of CPRX: BlackRock, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used